We are live on ! Find out more
Wolverine Trading

Wolverine Trading Portfolio holdings

AUM $139B
1-Year Est. Return 31.83%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+31.83%
3 Year Est. Return
+143.85%
5 Year Est. Return
+179.05%
10 Year Est. Return
AUM
$106B
AUM Growth
+$11.6B
Cap. Flow
+$4.96B
Cap. Flow %
4.66%
Top 10 Hldgs %
41.38%
Holding
6,018
New
1,317
Increased
2,241
Reduced
1,594
Closed
847

Sector Composition

Rank Sector Weight
1 Technology 0.91%
2 Consumer Discretionary 0.53%
3 Financials 0.31%
4 Healthcare 0.3%
5 Industrials 0.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WKSP icon
5126
Worksport
WKSP
$9.71M
$16.7K ﹤0.01%
+1,672
New +$11.8K
WKSP icon
5127
CALL
Worksport
WKSP
$9.71M
$16.7K ﹤0.01%
+1,670
New +$11.8K
GOSS icon
5128
Gossamer Bio
GOSS
$82.9M
$16.6K ﹤0.01%
18,912
+8,036
+74% +$6.88K
SENS icon
5129
PUT
Senseonics Holdings Inc
SENS
$263M
$16.3K ﹤0.01%
1,480
+155
+12% +$1.11K
SST icon
5130
CALL
System1
SST
$14.3M
$16.2K ﹤0.01%
1,940
+780
+67% +$7.85K
NEGG icon
5131
CALL
Newegg Commerce
NEGG
$279M
$16.2K ﹤0.01%
1,915
-5
-0.3% -$60
HRTX icon
5132
PUT
Heron Therapeutics
HRTX
$93.9M
$15.9K ﹤0.01%
+10,500
New +$17K
NINE
5133
DELISTED
Nine Energy Service
NINE
$15.7K ﹤0.01%
+15,808
New +$18.6K
CMLS
5134
CALL
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$15.5K ﹤0.01%
+22,500
New +$21.3K
MRSN
5135
DELISTED
Mersana Therapeutics
MRSN
$15.4K ﹤0.01%
+435
New +$22.5K
APLT
5136
DELISTED
Applied Therapeutics
APLT
$13.5K ﹤0.01%
+16,573
New +$104K
KPTI icon
5137
CALL
Karyopharm Therapeutics
KPTI
$43.5M
$13.3K ﹤0.01%
+1,267
New +$15.3K
WKHS icon
5138
PUT
Workhorse Group
WKHS
$33.2M
$13.3K ﹤0.01%
+119
New +$16.3K
AMRN
5139
CALL
Amarin Corp
AMRN
$299M
$13.2K ﹤0.01%
1,490
-30
-2% -$321
SENS icon
5140
Senseonics Holdings Inc
SENS
$263M
$13.1K ﹤0.01%
1,189
-303
-20% -$2.17K
KYNB
5141
CALL
Kyntra Bio
KYNB
$27.2M
$12.9K ﹤0.01%
+968
New +$8.99K
LXRX icon
5142
CALL
Lexicon Pharmaceuticals
LXRX
$1.03B
$12.6K ﹤0.01%
17,500
+5,600
+47% +$6.75K
OM icon
5143
CALL
Outset Medical
OM
$84.7M
$12.5K ﹤0.01%
+713
New +$8.9K
NINE
5144
CALL
DELISTED
Nine Energy Service
NINE
$12.5K ﹤0.01%
12,600
-3,300
-21% -$3.89K
CHPT icon
5145
ChargePoint
CHPT
$141M
$12.3K ﹤0.01%
553
-1,524
-73% -$37.7K
UBX
5146
CALL
DELISTED
Unity Biotechnology
UBX
$11.8K ﹤0.01%
+12,300
New +$15.3K
CODX
5147
CALL
Co-Diagnostics
CODX
$5.31M
$11.5K ﹤0.01%
+550
New +$17.4K
WWR icon
5148
CALL
Westwater Resources
WWR
$52.4M
$11.5K ﹤0.01%
+13,400
New +$7.7K
MCRB icon
5149
PUT
Seres Therapeutics
MCRB
$46.8M
$11.5K ﹤0.01%
690
-910
-57% -$14.8K
RLMD icon
5150
CALL
Relmada Therapeutics
RLMD
$557M
$11.1K ﹤0.01%
24,200
+3,100
+15% +$7.56K

Similar funds

Wolverine Trading's Q4 2024 Portfolio in Review

As of Q4 2024, Wolverine Trading held 6,018 positions worth $106B, up 12% from $94.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Wolverine Trading deployed $4.96B of net new capital in Q4 2024, opening 1,317 new positions and adding to 2,241 existing holdings. Its largest new stake was Blackrock: 30,914 shares worth $31.8M.

By sector, the portfolio is most concentrated in Technology at 0.91% of assets, up from 0.67% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $200M trimmed.

  • Wolverine Trading's largest Q4 2024 buy was Blackrock: 30,914 shares worth $31.8M.
  • Wolverine Trading added most to State Street Financial Select Sector SPDR ETF in Q4 2024, an estimated $68.4M increase.
  • Wolverine Trading's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $200M.
  • Wolverine Trading fully exited iShares Core S&P 500 ETF in Q4 2024, selling an estimated $219M.
  • Wolverine Trading's ten largest holdings make up 41% of its $106B portfolio in Q4 2024.
  • Wolverine Trading opened 1,317 new positions and closed 847 in Q4 2024.
  • Wolverine Trading's portfolio value rose 12% quarter-over-quarter to $106B.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.